A second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech updates
Adobe
By Meghana Keshavan
May 4, 2026
Biotech Correspondent
Meghana Keshavan
Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
A Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The Readout
Vivek Ramaswamy wins GOP primary for Ohio governor, CellCentric raises $220M for myeloma drug, and more biotech news
Vinay Prasad's acting replacement, remembering genomics pioneer J. Craig Venter, and more biotech news from The Readout
Latus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for Huntington's…
